Revinto Life Science Private Limited logo

Revinto Life Science Private Limited

Manufacturer and exporter of herbal medicines and supplements since 2003.
2003 | Uttara Kannada, Karnataka (India) | Active

Last Updated:

May 15, 2024
HomeCompanyRevinto Life Science Private Limited

Who are the key members and board of directors at Revinto Life Science?

Executive Team (1)

NameDesignationAppointment DateStatus
Jithendra Shetty InManaging Director31-Jul-2003Current

Board Members(2)

NameDesignationAppointment DateStatus
Prakhyath Shetty In Whole-Time Director 21-Jun-2018Current
Prasidh Shetty In Director Current

Financial Performance of Revinto Life Science.

Revinto Life Science Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

Charges (Loans)

Open Charges Satisfied Charges

₹5.37 Cr

₹6.61 Cr

LenderAmountStatus

Others

Creation Date: 11 Aug 2023
₹4.50 MOpen

Others

Creation Date: 30 Mar 2023
₹8.50 MOpen

Others

Creation Date: 28 Jul 2022
₹0.84 MOpen

How Many Employees Work at Revinto Life Science?

Revinto Life Science has a workforce of 78 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Revinto Life Science

Recent activity within the organization

  • Annual General Meeting

    Revinto Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Charges

    A charge registered on 01 Mar 2019 via Charge ID 100253860 with Others was fully satisfied on 27 Sep 2023.

    27 Sep 2023

  • Charges

    A charge with Others amounted to Rs. 0.45 Cr with Charge ID 100783951 was registered on 11 Aug 2023.

    11 Aug 2023

  • Balance Sheet

    Revinto Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.

    31 Mar 2023

  • Charges

    A charge with Others amounted to Rs. 0.85 Cr with Charge ID 100736945 was registered on 30 Mar 2023.

    30 Mar 2023

  • Charges

    A charge registered on 05 Feb 2016 via Charge ID 100060425 with Others was fully satisfied on 16 Nov 2022.

    16 Nov 2022

Frequently asked questions

  • Revinto Life Science Private Limited was incorporated on 31 Jul 2003.

  • The authorized share capital of Revinto Life Science Private Limited is ₹ 2.50 Cr and paid-up capital is ₹ 1.95 Cr.

  • Currently 3 directors are associated with Revinto Life Science Private Limited.

    • Jithendra Shetty
    • Prakhyath J Shetty
    • Prasidh Jithendra Shetty
  • As per Ministry of Corporate Affairs (Mca), the registered address of Revinto Life Science Private Limited is Plot No.21 Kiadb Industrial Area, Shirwad, Karwar, Karnataka, India, 581306.

  • The corporate identification number (CIN) of Revinto Life Science Private Limited is U05190KA2003PTC032339 and the company number is 032339 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Revinto Life Science Private Limited is https://www.prakrutiremedies.com

  • As Per 2021 financial reports, 78 employees are currently employed by Revinto Life Science Private Limited.

  • As per the financial statements for fiscal Year 2021, The total open charges for Revinto Life Science Private Limited amount to ₹ 5.37 Cr.

  • The most recent Balance Sheet for Revinto Life Science Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development